Repozytorium
Wyszukaj
Kolekcje
Inne
7-(4-Chlorophenyl)-1-hydroxy-5-methylpyrido[3,4-d]pyridazin-4(3H)-one: synthesis, solvatomorphism, in vitro anti-inflammatory and cytotoxic activity studies and in silico analysis
Autorzy
Rok wydania
2025
Czasopismo
Acta Crystallographica Section C: Structural Chemistry
Numer woluminu
81
Strony
198-211
DOI
10.1107/s2053229625001858
Kolekcja
Język
Angielski
Typ publikacji
Artykuł
The newly obtained compound 7-(4-chlorophenyl)-1-hydroxy-5-methylpyrido[3,4-d]pyridazin-4(3H)-one (CPM) was crystallized as two new variable solvates, namely, the dimethyl sulfoxide monosolvate, C14H10ClN3O2·C2H6SO (I), and the sesquisolvate, C14H10ClN3O2·1.5C2H6SO (II), and their structures were confirmed by single-crystal X-ray diffraction analysis. In previous work, 1-hydroxy-5-methyl-7-phenylpyrido[3,4-d]pyridazin-4(3H)-one (PM) was found to display anticancer activity. In the next step of our studies, we synthesized a new derivative of PM, introducing a Cl atom into the PM structure, obtaining CPM, which showed not only anticancer but also anti-inflammatory activity. CPM and the new semi-products of each step of the synthesis were examined by 1H NMR, 13C NMR and FT–IR spectroscopic analyses, and mass spectrometry. CPM forms (I) and (II) crystallize in the triclinic P1 and monoclinic C2/c space groups, respectively, and differ in the stoichiometry of the CPM and DMSO molecules in the crystal lattice, being 1:1 and 1:1.5 for (I) and (II), respectively. A powder X-ray diffraction analysis was performed only for solvate (I) due to the lack of stability of solvate (II). The potential cytotoxicity of CPM was evaluated against the normal cell lines L929 and RPTEC, as well as the cancer cell lines A172, AGS, CACO-2 and HepG2. The anti-inflammatory activity of CPM was also evaluated using colorimetric assay for the inhibition of COX-1 and COX-2. The same biological tests were carried out for PM to compare the activities of both compounds. The biological studies revealed that CPM does not exhibit more activity than PM. Moreover, in silico analysis of the bioavailability and molecular docking were performed.
Słowa kluczowe
pyrido[3,4-d]pyridazine derivatives, synthesis, pseudopolymorphic form, crystal structure, anti-inflammatory activity, cytotoxic activity, in silico analysis
Adres publiczny
Podobne publikacje
Structure and cytotoxic properties of 1-hydroxy-5-methyl-7-phenylpyrido[3,4-d]pyridazin-4(3H)-one and its mono- and disubstituted ethyl acetates
Wójcicka Anna, Becan Lilianna, Rembiałkowska Nina, Pyra Anna, Bryndal Iwona
Synthesis, crystal structure and cytotoxic activity of novel 5-methyl-4-thiopyrimidine derivatives.
Stolarczyk Marcin, Bryndal Iwona, Matera-Witkiewicz Agnieszka, Lis Tadeusz, Królewska-Golińska Karolina, Cieślak Marcin, Kaźmierczak-Barańska Julia, Cieplik Jerzy
Synthesis, structural characterization and anticancer activity of new 5-Trifluoromethyl-2-thioxo-thiazolo[4,5-d]pyrimidine derivatives
Becan Lilianna, Pyra Anna, Rembiałkowska Nina, Bryndal Iwona